You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest International Articles
Popular International Articles
Highly Recommended International Articles
Send a link to this page to your friends and colleagues.
Researchers at the University of Naples in Naples, Italy, observed 64 men with type 2 who had an average age of 60 years as well as similar body mass indexes, A1C levels and diabetes duration. The men were divided into two groups: those with microalbuminuria (abnormal levels of the protein albumin in the urine) and high blood pressure, and those with microalbuminuria and normal blood pressure.
Participants received either 150 mg doses of Avapro twice daily or a placebo for 60 days. After 15 days of washout, the placebo group also received Avapro.
In participants with microalbuminuria and high blood pressure, Avapro reduced 24-hour systolic and diastolic pressure and AER. In participants with microalbuminuria and normal blood pressure, Avapro reduced AER.
The researchers conclude that Avapro's beneficial effects on AER are independent of its anti-hypertensive effects.
Previous research has also demonstrated that the ACE inhibitor drug class can provide the same benefit.
* * *
—Diabetes Care, November 2002
0 comments - Jan 1, 2003
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.